Skip to content

OptimizeRx OPRX Common Stock

Common Stock at other companies

Veeva Systems logo
Veeva SystemsVEEV
$2K0.0%
Phreesia logo
PhreesiaPHR
$632K+3.9%
Doximity logo
DoximityDOCS
$183K-3.2%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$34K-5.6%
PubMatic logo
PubMaticPUBM
$7K+16.7%
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
80M0.0%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's common stock?
OptimizeRx (OPRX) reported common stock of 166.7M in Q1 2026.
How has OptimizeRx's common stock changed year-over-year?
OptimizeRx's common stock decreased by 0.0% year-over-year, from 166.7M to 166.7M.
What is the long-term trend for OptimizeRx's common stock?
Over 5 years (2020 to 2025), OptimizeRx's common stock has grown at a 0.0% compound annual growth rate (CAGR), from 166.7M to 166.7M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).